This study is testing an investigational drug called rosnilimab for people with moderate to severe ulcerative colitis (UC) who haven't gotten enough relief from other standard treatments. About 132 participants will be randomly assigned to receive either the drug or a placebo (in…
Phase: PHASE2 • Sponsor: AnaptysBio, Inc. • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC